SPIA
ARCT icon

Steward Partners Investment Advisory’s Arcturus Therapeutics ARCT Stock Holding History

Steward Partners Investment Advisory’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$787 Hold
102
– – ﹤0.01% 4218
2025
Q4 		$625 Hold
102
– – ﹤0.01% 4132
2025
Q3 		$1.88K Buy
+102
New +$1.64K ﹤0.01% 3935
2021
Q2 		– Sell
-200
Closed -$8.26K – 7088
2021
Q1 		$8.26K Buy
+200
New +$11.9K ﹤0.01% 2857

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Steward Partners Investment Advisory's ARCT Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Arcturus Therapeutics (ARCT) position steady in Q1 2026 at 102 shares worth $787. The position accounts for ﹤0.01% of the portfolio, ranked #4218.

Steward Partners Investment Advisory first reported a position in ARCT in Q1 2021 and has held it in 4 quarters since. The position peaked at $8.26K in Q1 2021. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Steward Partners Investment Advisory held 102 shares of Arcturus Therapeutics worth $787 as of Q1 2026.
  • Steward Partners Investment Advisory left its Arcturus Therapeutics share count unchanged in Q1 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4218 holding.
  • Steward Partners Investment Advisory first reported a position in Arcturus Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • Steward Partners Investment Advisory's Arcturus Therapeutics position peaked at $8.26K in Q1 2021.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.